The article focuses on the misconceptions about the BRCA1 or BRCA2 mutation gene for hereditary breast and ovarian cancer. It discusses how the increased cancer risk statistics impacts the men and women with BRCA mutation with hereditary carriers, knowing details on a potential germline mutation and its indication through genetic testing.